Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice

Citation
Cm. Stach et al., Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice, CELL DEAT D, 7(10), 2000, pp. 911-915
Citations number
37
Categorie Soggetti
Cell & Developmental Biology
Journal title
CELL DEATH AND DIFFERENTIATION
ISSN journal
13509047 → ACNP
Volume
7
Issue
10
Year of publication
2000
Pages
911 - 915
Database
ISI
SICI code
1350-9047(200010)7:10<911:TWAVII>2.0.ZU;2-W
Abstract
Exposure of phosphatidylserine on the outer leaflet of the cytoplasmic memb rane is an early event during apoptotic cell death and serves as a recognit ion signal for phagocytes. Usually the clearance of apoptotic cells does no t initiate inflammation or immune response. We investigated the immune resp onse in Balb/c mice towards apoptotic human T-cells, Animals injected with apoptotic cells showed significantly reduced humoral immune responses, espe cially Th1-dependent IgG2a titres, compared to controls immunised with viab le cells, However, treatment of apoptotic cells with annexin V (AxV) signif icantly increased the humoral immune response, AxV binds with high affinity to anionic phospholipids and as a result interferes with the phosphatidyls erine recognition by phagocytes, Our results indicate that AxV treatment ma y be used to increase the efficiency of apoptotic cell-based vaccines, e.g. some tumour vaccines.